Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
21.90
-0.41 (-1.84%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Company Description

Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.

The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.

It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services.

In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services.

The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny, Inc.
Progyny logo
Country United States
Founded 2008
IPO Date Oct 25, 2019
Industry Healthcare Plans
Sector Healthcare
Employees 680
CEO Peter Anevski

Contact Details

Address:
1359 Broadway
New York, New York 10018
United States
Phone 212 888 3124
Website progyny.com

Stock Details

Ticker Symbol PGNY
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $13.00
CIK Code 0001551306
CUSIP Number 74340E103
ISIN Number US74340E1038
Employer ID 27-2220139
SIC Code 8090

Key Executives

Name Position
Peter Anevski CPA Chief Executive Officer and Director
David J. Schlanger J.D. Executive Chairman
Michael Sturmer President
Mark S. Livingston CPA Chief Financial Officer
Allison Swartz Executive Vice President, General Counsel and Secretary
Steven Leist Chief Technology Officer
James Hart Vice President of Investor Relations
Risa Fisher Chief Marketing Officer
Cassandra Pratt Chief Human Resources Officer
Julie Stadlbauer Chief Business Development Officer

Latest SEC Filings

Date Type Title
Mar 3, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 3, 2025 10-K Annual Report
Feb 28, 2025 8-K/A [Amend] Current report
Feb 27, 2025 8-K Current Report
Jan 16, 2025 8-K Current Report
Jan 13, 2025 8-K Current Report
Dec 9, 2024 144 Filing
Dec 6, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 10-Q Quarterly Report